PCN35 COST-EFFECTIVENESS ANALYSIS OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT OR INTOLERANT CML PATIENTS IN BRAZIL
May 1, 2008, 00:00
10.1016/S1098-3015(10)70213-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)70213-8/fulltext
Title :
PCN35 COST-EFFECTIVENESS ANALYSIS OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT OR INTOLERANT CML PATIENTS IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70213-8&doi=10.1016/S1098-3015(10)70213-8
First page :
Section Title :
Open access? :
No
Section Order :
860